Remarkably, we found that the mode of therapy, HPV status, smoking status, alcohol intake, tumor stage, and gene methylation status all indicated the likelihood of recurrence in patients with methylated NPY1R and NPY2R promoters. Here, NPY1R is linked to neoplasm.